Zymosense
Ames
About Zymosense
Zymosense provides automated aqueous two-phase extraction for low-cost and scalable sorting of chiral-pure single-walled carbon nanotubes and a proof-of-concept demonstration for automating the NIST-developed ATP system for separating chiral-pure single-walled carbon nanotubes, enabling different industries to get access to rapid evaluation, discovery, and design of new enzymes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $256.0K
- Last round: Grant (Jun 2022)
- Website: zymosense.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/zymosense-18526 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.